Therapy News and Research

RSS

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Vertex Pharmaceuticals Incorporated today announced that abstracts from its hepatitis C program, including two late-breaking posters from studies of INCIVEK (telaprevir) tablets and VX-222, were accepted for presentation at The Liver Meeting, the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, November 4-8, 2011.

1 Oct 2011

Nutrition experts participated in PN Safety Summit to discuss safety of PN therapy, patient care

Recent safety concerns in the preparation and delivery of parenteral nutrition, commonly referred to as intravenous nutrition, prompted leaders from several major organizations to participate in a PN Safety Summit on September 23, 2011.

From Baxter International Inc. 1 Oct 2011

The West Clinic forms new comprehensive breast center

The West Clinic, the Mid-South's premier cancer practice, is pleased to announce the formation of The West Clinic Comprehensive Breast Center, a multidisciplinary breast center, which will be the first center of its kind in the region.

1 Oct 2011

Scientists discover that DNA modifications in brain cells change due to stimulated brain activity

Johns Hopkins scientists investigating chemical modifications across the genomes of adult mice have discovered that DNA modifications in non-dividing brain cells, thought to be inherently stable, instead underwent large-scale dynamic changes as a result of stimulated brain activity.

1 Oct 2011

UCI study shows promise of metabolic therapy for autoimmune diseases

A glucosamine-like dietary supplement suppresses the damaging autoimmune response seen in multiple sclerosis, according to a UC Irvine study.

1 Oct 2011

USAID interviews Kenyan government staff regarding Cabinet memorandum outlining HIV program fundraising options

USAID's "IMPACTblog" interviews Regina Ombam, head of strategy for the Kenya National AIDS Control Council (NACC), and Irene Mukui, the antiretroviral therapy (ART) program manager for Kenya's National AIDS and STI Control Program, regarding a Cabinet memorandum prepared by the NACC in March that outlines ways to raise funds for HIV programming.

1 Oct 2011

Circadian subsidiary submits IND application to FDA to initiate VGX-100 study against cancer

Circadian Technologies Limited is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug application to the U.S. Food and Drug Administration to initiate clinical studies of VGX-100.

1 Oct 2011

Baxter seeks European marketing authorization for HyQ to treat PI

Baxter International Inc. announced today that it has submitted an application to the European Medicines Agency's Committee for Human Medicinal Products seeking marketing authorization for HyQ. HyQ is Baxter's investigational immunoglobulin (IG) therapy administered subcutaneously and facilitated by recombinant human hyaluronidase, a dispersion and permeation enhancer, for use in patients with primary immunodeficiencies.

From Baxter International Inc. 1 Oct 2011

First Edition: September 30, 2011

Today's headlines include reports about how new and old health policy positions are playing on the campaign trail.

30 Sep 2011

ALK gene discovered by St. Jude scientists associated with FDA approved adult cancer drug

A drug recently approved by the U.S. Food and Drug Administration for treatment of an adult cancer targets a malfunctioning gene discovered more than a decade earlier at St. Jude Children's Research Hospital. The story highlights how scientific findings from St. Jude can be translated into therapies and tests that in addition to helping children, also help adults.

30 Sep 2011

Kimmel Cancer Center at Jefferson celebrates two decades of caring and collaboration to beat cancer

From October forward, the Kimmel Cancer Center at Jefferson (KCC), a National Cancer Institute-designated cancer center, is celebrating 20 years of service to the community and the groundbreaking cancer research from the scientists and physicians who've provided an invaluable contribution to medical science and healthcare.

30 Sep 2011

Researchers develop HTGTS to map translocatome in the genome

Researchers at Children's Hospital Boston and the Immune Disease Institute (IDI) have created a method for mapping "hot spots" in the genome where chromosomes are most likely to break and recombine, knowledge that helps define the rules that govern when and where breaks occur.

30 Sep 2011

MU researchers examine use of propranolol to improve primary traits linked with autism

Most drug therapy interventions for people with autism have targeted psychiatric problems, including aggression, anxiety and obsessive behavior. Now, University of Missouri researchers are examining the use of propranolol to improve the primary traits associated with autism - difficulty with normal social skills, language and repetitive behaviors.

30 Sep 2011

First patient in Turkey with Total Artificial Heart attends TUYOD meeting

In May 2011, Omer Bayrak made headlines when he became the first patient in Turkey to be discharged from the hospital using the Freedom® portable driver to power his SynCardia temporary Total Artificial Heart. Since returning home to wait for a matching donor heart, Mr. Bayrak has been enjoying his new-found celebrity as "the only man in Turkey who lives without a heart."

30 Sep 2011

Patients with chronic hepatitis C less likely to take medications over time

Patients being treated for chronic hepatitis C become less likely to take their medications over time, according to a new study from the Perelman School of Medicine at the University of Pennsylvania.

30 Sep 2011

Cincinnati Children's to conduct first medication clinical trial for pediatric migraine

Cincinnati Children's Hospital Medical Center has received a $12 million grant from the National Institutes of Health to conduct the first clinical trial to determine the medication of choice for preventing migraines in children and teens.

30 Sep 2011

Immunotherapeutics for treatment of metastatic melanoma

A new cancer research program at Loyola University Chicago Stritch School of Medicine will develop therapies designed to turn patients' own immune systems into potent weapons against cancer.

30 Sep 2011

Researchers identify set of proteins that affect development of varicose veins

A new discovery published in the October 2011 print issue of The FASEB Journal explains for the first time what kicks off the process that causes varicose veins.

30 Sep 2011

Resveratrol inhibits proliferation of hormone resistant breast cancer cells

Cheers! A new research report appearing in the October 2011 issue of The FASEB Journal shows that resveratrol, the "healthy" ingredient in red wine, stops breast cancer cells from growing by blocking the growth effects of estrogen.

30 Sep 2011

G-Zero receives NIAID's Phase II Small Business Innovation Research Grant

G-Zero Therapeutics, an RTP company started in 2008 based on technologies from the University of North Carolina at Chapel Hill, has been awarded a $3 million Phase II Small Business Innovation Research Grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

30 Sep 2011

Therapy News and Research

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Nutrition experts participated in PN Safety Summit to discuss safety of PN therapy, patient care

The West Clinic forms new comprehensive breast center

Scientists discover that DNA modifications in brain cells change due to stimulated brain activity

UCI study shows promise of metabolic therapy for autoimmune diseases

USAID interviews Kenyan government staff regarding Cabinet memorandum outlining HIV program fundraising options

Circadian subsidiary submits IND application to FDA to initiate VGX-100 study against cancer

Baxter seeks European marketing authorization for HyQ to treat PI

First Edition: September 30, 2011

ALK gene discovered by St. Jude scientists associated with FDA approved adult cancer drug

Kimmel Cancer Center at Jefferson celebrates two decades of caring and collaboration to beat cancer

Researchers develop HTGTS to map translocatome in the genome

MU researchers examine use of propranolol to improve primary traits linked with autism

First patient in Turkey with Total Artificial Heart attends TUYOD meeting

Patients with chronic hepatitis C less likely to take medications over time

Cincinnati Children's to conduct first medication clinical trial for pediatric migraine

Immunotherapeutics for treatment of metastatic melanoma

Researchers identify set of proteins that affect development of varicose veins

Resveratrol inhibits proliferation of hormone resistant breast cancer cells

G-Zero receives NIAID's Phase II Small Business Innovation Research Grant

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News